Precision oncology is transforming cancer treatment by replacing broad trial-and-error approaches with individualized therapies based on tumor biology. This article compares chemotherapy and ... Aug 10
Precision oncology is transforming cancer care by shifting from traditional trial-and-error treatments to personalized therapies based on each patient’s unique molecular profile. ... Jul 04
Transgene , a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Bio B.V. ... Apr 04
Everest Medicines today announced that the first patient has been enrolled in a global multi-center Phase I clinical trial of its Tumor-Associated Antigen ... Oct 15
Pharma merger and acquisition news... Jul 22
Gritstone Oncology advances into phase 2 expansion cohorts for its personalized neoantigen immunotherapy GRANITE and its off-the-shelf neoantigen immunotherapy SLATE ... Nov 03
European Commission approves Roche’s Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer.... Nov 02
Collaboration for Two Ongoing Clinical Trials for Patients with Ovarian and Head & Neck Cancers... Oct 07
... Sep 23
-Advertisements-